Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-20

FDA Approved: VIBERZI — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for VIBERZI (eluxadoline). This action approves changes requested in the supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viberzi (eluxadoline)

Snippet

SUPPL AP for VIBERZI (ELUXADOLINE)